‘The patient’: at the center of patient-reported outcomes
Author:
- 9 August 2015
- journal article
- editorial
- Published by Taylor & Francis in Expert Review of Pharmacoeconomics & Outcomes Research
- Vol. 15 (5) , 729-731
Abstract
The recent emphasis of including patient reports in their own care management is reviewed in terms of the factors that contributed to its popularity. The role change of patients as being active par...Keywords
This publication has 14 references indexed in Scilit:
- The Impact of Newer Atypical Antipsychotics on Patient-Reported Outcomes in SchizophreniaCNS Drugs, 2013
- Subjective tolerability of antipsychotic medications and the emerging science of subjective tolerability disordersExpert Review of Pharmacoeconomics & Outcomes Research, 2010
- The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychoticsInternational Journal of Neuropsychopharmacology, 2009
- Correlation of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophreniaSchizophrenia Research, 2007
- Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia — Findings from an in vivo SPECT studySchizophrenia Research, 2006
- Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidanceHealth and Quality of Life Outcomes, 2006
- Impact of Atypical Antipsychotics on Quality of Life in Patients with SchizophreniaCNS Drugs, 2004
- The subjective/objective dichotomy in schizophrenia - relevance to nosology, research and management2002
- Subjective Experience and Striatal Dopamine D2 Receptor Occupancy in Patients With Schizophrenia Stabilized by Olanzapine or RisperidoneAmerican Journal of Psychiatry, 2000
- Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliabilityPsychological Medicine, 1998